Skip to main content

Advertisement

Figure 1 | Arthritis Research & Therapy

Figure 1

From: Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity

Figure 1

CX3CL1 expressions in affected muscle of patients with polymyositis and patients with dermatomyositis. Muscle specimens from (A, B) controls, (C, D, G, H) polymyositis (PM) patients, and (E, F) dermatomyositis (DM) patients were stained with anti-CX3CL1 mAb (A, C, E, G) or an isotype-matched control mAb (B, D, F, H). Original magnification, ×200.

Back to article page